Dr. Farrukh M. Koraishy summarizes the results of his study, "Geographic and Temporal Trends in COVID-Associated Acute Kidney Injury in the National COVID Cohort Collaborative," on behalf of his colleagues.

Dr. Nick Larkins discusses the finding of his study, "Timing of Kidney Replacement Therapy among Children and Young Adults," on behalf of his colleagues.

Dr. Gangadharan Komala provides a summary of the results of his study, "Kidney Adverse Events Associated with Immune Checkpoint Inhibitor Therapy," on behalf of his colleagues.

Mr. Pierre Giguère and Dr. Swapnil Hiremath provide an overview of their study, "Management and Outcome of COVID-19 Infection Using Nirmatrelvir/Ritonavir in Kidney Transplant Patients," on behalf of their colleagues.

Drs. Calyani Ganesan, Alan Pao, and John Leppert discuss the results of their study, "Kidney Stone Events after Kidney Transplant in the United States," on behalf of their colleagues.

Dr. Hiddo J.L. Heerspink summarizes the findings of his study, "Glycemic Control and Effects of Canagliflozin in Reducing Albuminuria and eGFR," on behalf of his colleagues.

Dr. Nora Franceschini and Ms. Kaylia Reynolds summarize the findings of their study "Circulating Metabolites Associated with Albuminuria in a Hispanic/Latino Population," on behalf of their colleagues.

Dr. Kendra Wulczyn discusses the results of her study "Incidence and Risk Factors for Pruritus in Patients with Nondialysis CKD," on behalf of her colleagues.

A Vision for CJASN, Rajnish Mehrotra, MD, MS: In this inaugural podcast, and his first month as the new Editor-in-Chief of CJASN, Dr. Mehrotra discusses his vision to cement CJASN as the leading voice in communicating and influencing advances in clini...